Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v6-FR
Language French French
Date Updated 2020-09-08 2020-06-22
Drug Identification Number 02243737 02243737
Brand name PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD
Common or Proper name PHENTOLAMINE MES PHENTOLAMINE MES
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients PHENTOLAMINE MESYLATE PHENTOLAMINE MESYLATE
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 1ml X 10vials 1ml X 10vials
ATC code C04AB C04AB
ATC description PERIPHERALVASODILATORS PERIPHERALVASODILATORS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-03-25 2020-03-25
Estimated end date 2020-09-25 2020-07-24
Actual end date 2020-09-04
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments